Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies
Affiliations
- PMID: 2353018
Item in Clipboard
Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies
Prog Clin Biol Res.
1990.
No abstract available
Similar articles
-
Immunomodulation of cancer with activated cytotoxic leukocytes.Prog Clin Biol Res. 1990;337:435-8. Prog Clin Biol Res. 1990. PMID: 2191333 Review. No abstract available.
-
[Tumoricidal biological response modifiers (BRM)].Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1407-13. Gan To Kagaku Ryoho. 1990. PMID: 1697152 Review. Japanese.
-
Biological response modifiers: current use and future prospects in cancer therapy.Indian J Cancer. 2010 Oct-Dec;47(4):443-51. doi: 10.4103/0019-509X.73559. Indian J Cancer. 2010. PMID: 21131760 Review.
-
Immunotherapeutic strategies for neoplasia.Dev Biol Stand. 1992;77:17-28. Dev Biol Stand. 1992. PMID: 1426659 Review. No abstract available.
-
Biological response modifiers.Cancer Chemother Biol Response Modif. 1993;14:207-26. Cancer Chemother Biol Response Modif. 1993. PMID: 8312103 Review. No abstract available.